HAP Trading’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-114,100
| Closed | -$5.01K | – | 874 |
|
|
2023
Q4 | $5.01K | Buy |
+114,100
| New | +$13.9M | ﹤0.01% | 781 |
|
|
2022
Q3 | – | Sell |
-56,300
| Closed | -$96K | – | 1883 |
|
|
2022
Q2 | $96K | Buy |
+56,300
| New | +$6.68M | ﹤0.01% | 900 |
|
|
2021
Q2 | – | Sell |
-44,100
| Closed | -$173K | – | 2513 |
|
|
2021
Q1 | $173K | Buy |
44,100
+30,300
| +220% | +$4.81M | 0.01% | 806 |
|
|
2020
Q4 | $12K | Buy |
+13,800
| New | +$1.97M | ﹤0.01% | 1860 |
|
|
2020
Q3 | – | Sell |
-11,500
| Closed | -$21K | – | 1717 |
|
|
2020
Q2 | $21K | Buy |
+11,500
| New | +$1.47M | ﹤0.01% | 1297 |
|
|
2020
Q1 | – | Sell |
-101,500
| Closed | -$20K | – | 1347 |
|
|
2019
Q4 | $20K | Buy |
101,500
+19,900
| +24% | +$2.22M | ﹤0.01% | 882 |
|
|
2019
Q3 | $273K | Buy |
81,600
+800
| +1% | +$83.7K | 0.02% | 433 |
|
|
2019
Q2 | $190K | Sell |
80,800
-102,400
| -56% | -$10.9M | 0.01% | 504 |
|
|
2019
Q1 | $224K | Buy |
183,200
+138,500
| +310% | +$15.2M | 0.02% | 425 |
|
|
2018
Q4 | $554K | Buy |
44,700
+34,000
| +318% | +$3.61M | 0.03% | 347 |
|
|
2018
Q3 | $13K | Sell |
10,700
-375,200
| -97% | -$44.2M | ﹤0.01% | 812 |
|
|
2018
Q2 | $405K | Buy |
385,900
+374,900
| +3,408% | +$40.1M | 0.02% | 356 |
|
|
2018
Q1 | $54K | Sell |
11,000
-58,100
| -84% | -$6.44M | ﹤0.01% | 627 |
|
|
2017
Q4 | $281K | Buy |
69,100
+21,100
| +44% | +$2.26M | 0.01% | 454 |
|
|
2017
Q3 | $72K | Sell |
48,000
-66,900
| -58% | -$7.15M | ﹤0.01% | 613 |
|
|
2017
Q2 | $155K | Buy |
114,900
+64,200
| +127% | +$6.32M | 0.01% | 545 |
|
|
2017
Q1 | $80K | Sell |
50,700
-438,900
| -90% | -$42M | ﹤0.01% | 597 |
|
|
2016
Q4 | $2.61M | Buy |
489,600
+447,000
| +1,049% | +$40.7M | 0.13% | 133 |
|
|
2016
Q3 | $54K | Sell |
42,600
-53,100
| -55% | -$5.05M | ﹤0.01% | 691 |
|
|
2016
Q2 | $393K | Sell |
95,700
-700,500
| -88% | -$62.9M | 0.02% | 353 |
|
|
2016
Q1 | $1.18M | Buy |
796,200
+511,800
| +180% | +$45.8M | 0.09% | 188 |
|
|
2015
Q4 | $102K | Buy |
284,400
+179,700
| +172% | +$19.5M | ﹤0.01% | 551 |
|
|
2015
Q3 | $815K | Sell |
104,700
-367,800
| -78% | -$44.1M | 0.04% | 293 |
|
|
2015
Q2 | $735K | Buy |
472,500
+322,500
| +215% | +$38.6M | 0.04% | 305 |
|
|
2015
Q1 | $973K | Buy |
150,000
+56,100
| +60% | +$6.19M | 0.07% | 251 |
|
|
2014
Q4 | $4K | Sell |
93,900
-478,800
| -84% | -$46.5M | ﹤0.01% | 969 |
|
|
2014
Q3 | $376K | Sell |
572,700
-508,200
| -47% | -$44.6M | 0.01% | 509 |
|
|
2014
Q2 | $983K | Sell |
1,080,900
-1,124,100
| -51% | -$88.6M | 0.04% | 327 |
|
|
2014
Q1 | $3.55M | Buy |
2,205,000
+1,855,500
| +531% | +$155M | 0.16% | 117 |
|
|
2013
Q4 | $64K | Buy |
+349,500
| New | +$24.8M | ﹤0.01% | 853 |
|
Other funds holding IBB
CB
HAP Trading's IBB Position: Q1 2023 in Review
HAP Trading sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 10,063 shares — an estimated $1.32M sold.
HAP Trading first reported a position in IBB in Q3 2013 and held it in 10 quarters. The position peaked at $14.9M in Q4 2014. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.
- HAP Trading reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
- HAP Trading sold 10,063 iShares Biotechnology ETF shares in Q1 2023, an estimated $1.32M.
- HAP Trading first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 10 quarters.
- HAP Trading's iShares Biotechnology ETF position peaked at $14.9M in Q4 2014.
- 867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.
Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.